Treatment for inflammatory bowel disease with VLA-4 blockers
US5932214A · kind A · utility
44Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1997 |
| Grant date | Aug 3, 1999 |
| Priority date | — |
| Expiry date | Oct 15, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2842
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment of inflammatory bowel disease (IBD) is disclosed. The method comprises administration of an antibody, polypeptide or other molecule recognizing VLA-4, a surface molecule expressed on most types of white blood cells and involved in leukocyte adhesion to endothelium and other tissus in the gut.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.